日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Study finds virus antibodies last at least 12 months

By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-08 09:27
Share
Share - WeChat
A recovering pneumonia patient gives a thumbs-up to medical workers at Wuhan University's Zhongnan Hospital, in early 2020. [GAO XIANG/FOR CHINA DAILY]

Antibodies against the novel coronavirus can last for at least 12 months in more than 70 percent of recovered COVID-19 patients, a study published by Chinese researchers on Tuesday shows.

The finding adds to growing evidence that vaccination, which elicits an immune response in a way similar to how a live virus triggers human bodies to generate antibodies, can "effectively restrict the spread of SARS-CoV-2", the study said.

The study, published online by Nature Communications, was conducted by China National Biotech Group, a Sinopharm subsidiary, and the National Research Center for Translational Medicine at Shanghai Jiao Tong University.

Researchers collected 1,782 convalescent plasma samples from 869 recovered COVID-19 patients in Wuhan, Hubei province, within 12 months of diagnosis, and tested them for the presence and amount of RBDIgG, a type of antibody that indicates the strength of immunity against the virus.

Testing results showed that in nine months, levels of the antibody dropped to 64.3 percent of the initial level when they contracted the virus, and then stabilized into the 12th month.

"It shows that once immune responses against the novel coronavirus are induced in human bodies, antibody levels can be maintained for quite a long time," China National Biotech Group said in an article on its WeChat account on Wednesday.

The study found that the antibody response was significantly stronger in male participants than in their female counterparts in the early stages of infection, but the difference dwindled over time and nearly disappeared in 12 months.

Among participants aged 18 to 55, the older ones developed higher antibody levels, it added.

The company said the study is the longest-running research aimed at examining the persistence of antibody response in recovered COVID-19 patients.

The finding was published as mass vaccination in China proceeds smoothly, with the country stepping up vaccine donations or sales overseas.

As of Tuesday, about 1.3 billion doses of vaccines had been administered nationwide, the National Health Commission said on Wednesday.

China National Biotech Group added that the study will help improve understanding of the immunological memory elicited by the virus, and provide guidance on future research into vaccine-induced immunity and future vaccination policies in China and abroad.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美激情久久久久久久久 | 国产精品亚洲视频 | 三级网站日本 | 亚洲国产精品一区二区第一页 | 亚洲视频在线观看 | 双性精h调教灌尿打屁股的文案 | 中文线码中文高清播放中 | 奇米影视在线观看 | 国产精品久久久久久久y | 99久热国产精品视频尤物不卡 | 一区二区三区高清在线观看 | 国产免费叼嘿在线观看 | 亚洲一区二区在线 | 亚洲国产中文字幕 | 人人曰 | www.夜夜操.com| 黄视频网站免费看 | 播五月婷婷| 日本中文字幕高清 | 免费观看视频91 | 日韩综合| 色蜜桃网| 国产高清在线视频 | 狠狠影院 | 成人精品一区二区三区 | 欧美亚洲一区二区三区 | 亚洲成人综合视频 | 亚洲欧美日韩高清一区二区三区 | 国产裸体bbb视频 | 色综合天天综合网国产成人网 | 岛国毛片一级一级特级毛片 | 亚洲精品一区二区三区在线看 | 国产成人精品一区二区三区电影 | 国产精品第八页 | 免费播放欧美一级特黄 | 色噜噜狠狠色综合日日 | 亚洲精品视频在线 | 波多野结衣VR全景3D | 日本高清免费不卡在线播放 | 四虎884aa永久播放地址http | 视频成人永久免费视频 |